期刊文献+

乌司他丁对法洛四联症根治术婴幼儿炎性反应的影响和心肌保护作用 被引量:2

下载PDF
导出
摘要 近年来,随着体外循环(CPB)技术手术技巧及麻醉技术等的大幅提高,CPB在心脏手术中对机体的影响越来越小,但其毕竟是一种非生理的循环方式,血液与异物表面相接触以及由此触发的相关炎症反应可导致全身血管和器官实质的病理改变,从而影响术后机体的恢复。近年来,与CPB相关的机体损伤问题主要集中在肾、肺、肝等器官,对心肌的损伤研究较少。
出处 《中国药物与临床》 CAS 2016年第8期1181-1183,共3页 Chinese Remedies & Clinics
  • 相关文献

参考文献6

  • 1Sato Y,Ishikawa S,Otaki A,et al.Induction of acute-phase reactive substances during open-heart surgery and efficacy of Ulinastatin.Inhibiting cytokines and postoperative organ injury[J].Jpn J Thorac Cardiovasc Surg,2000,48(7):428-434.
  • 2吉冰洋.体外循环中乌司他丁对机体的保护作用[J].中国胸心血管外科临床杂志,2002,9(1):51-53. 被引量:36
  • 3Miura M,Sugiura T,Aimi Y.Effects of ulinastatin on PMNL and vascular endothelial injury in patients undergoing open heart surgery with CPB[J].Masui,1998,47(1):29-35.
  • 4Hiyama A,Takeda J,Kotate Y,et al.A human urinary protease inhibitor(ulinastatin)inhibits neutrophil extracellular release of elastase during cardiopulmonary bypass[J].J Cardiothorrac Vase Anesth,1997,11(5):580-584.
  • 5张剑蔚,陈煜,朱明,顾洪斌.不同剂量乌司他丁在婴幼儿体外循环中的肺保护作用[J].上海第二医科大学学报,2004,24(11):933-935. 被引量:5
  • 6Sugita T,Watarida S,Katsuyama K,et al.Effect of a human urinary protease inhibitor(Ulinastatin)on respiratory function in pediatric patients undergoing cardiopulmonary bypass[J].J Cardiovasc Surg(Torino),2002,43(4):437-440.

二级参考文献22

  • 1[1]Sato Y,Ishikawa S,Otaki A,et al.Induction of acute-phase reactive substances during open-heart surgery and efficacy of ulinastatin.Inhibiting cytokines and postoperative organ injury.Jpn J Thorac Cardiovasc Surg,2000,48(7):428-434.
  • 2[2]Conlon PJ,Stafford-Smith M,White WD,et al.Acute renal failure following cardiac surgery.Nephrol Dial Transplant,1999,14(5):1158-1162.
  • 3[3]Suen WS,Mok CK,Chiu SW,et al.Risk factors for development of acute renal failure(ARF) requiring dialysis in patients undergoing cardiac surgery.Angiology,1998,49(10):789-800.
  • 4[4]Oshima N,Yamada T,Nakahara H,et al.Effect of ulinastatin(UL) on renal function and lactic acidosis during open-heart surgery:comparison with aprotinin.Kyobu Geka,1990,43(5):357-363.
  • 5[5]Ueki M,Yokono S,Nogaya J,et al.Effects of ulinastatin on postoperative renal function after cardiopulmonary bypass.Masui,1995,44(5):691-697.
  • 6[6]Yonoko S,Ueki M,Nakayo M,et al.Urinary excretion of ulinastatin and NAG after cardiopulmonary bypass.Masui,1997,46(3):388-392.
  • 7[7]Ueki M,Yokono S,Komatsu H,et al.The support of postoperative renal function by ulinastatin inpatients with preoperative renal dysfunction.Masui,1995,44(4):570-573.
  • 8[8]Nakakuki M,Yamasaki F,Shinkawa T,et al.Protective effect of human ulinastatin against gentamicin-induced acute renal failure in rats.Can J Physiol Pharmacol,1996,74(1):104-111.
  • 9[9]Ueki M,Yokono S,Taie S,et al.Supplement of ulinastatin on renal function after cardiopulmonary bypass.Masui,2000,49(2):163-167.
  • 10[10]Tanita T,Song C,Kubo H,et al.Superoxide anion mediates pulmonary vascular permeability caused by neutrophils in cardiopulmonary bypass.Surg Today,1999,29(8):755-761.

共引文献38

同被引文献9

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部